USP9X-mediated REV1 deubiquitination promotes lung cancer radioresistance via the action of REV1 as a Rad18 molecular scaffold for cystathionine γ-lyase

Yunshang Chen,Xue Feng,Zilong Wu,Yongqiang Yang,Xinrui Rao,Rui Meng,Sheng Zhang,Xiaorong Dong,Shuangbing Xu,Gang Wu,Xiaohua Jie
DOI: https://doi.org/10.1186/s12929-024-01044-3
2024-05-29
Journal of Biomedical Science
Abstract:Radioresistance is a key clinical constraint on the efficacy of radiotherapy in lung cancer patients. REV1 DNA directed polymerase (REV1) plays an important role in repairing DNA damage and maintaining genomic stability. However, its role in the resistance to radiotherapy in lung cancer is not clear. This study aims to clarify the role of REV1 in lung cancer radioresistance, identify the intrinsic mechanisms involved, and provide a theoretical basis for the clinical translation of this new target for lung cancer treatment.
cell biology,medicine, research & experimental
What problem does this paper attempt to address?